Levonorgestrel - HRA Pharma

Drug Profile

Levonorgestrel - HRA Pharma

Alternative Names: Duofem; NorLevo; Norlevo; SOH-075; SOT-075; Vikela

Latest Information Update: 30 Jan 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator HRA Pharma
  • Developer Sosei
  • Class Hormonal replacements; Norpregnanes; Oral contraceptives; Small molecules
  • Mechanism of Action Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Pregnancy

Most Recent Events

  • 10 Sep 2014 Biomarkers information updated
  • 27 Jan 2014 Sosei transfers the Japan marketing authorisation for levonorgestrel to ASKA Pharmaceutical
  • 29 Mar 2012 Nycomed is now called Takeda Pharmaceuticals International GmbH
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top